Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukiko Abe

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Cancer Medicine|August 29, 2023
Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit studySatoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
Clinical Colorectal Cancer|February 8, 2024
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit StudySatoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 14, 2023
The Role of a Composite Fitness Score in the Association Between Low-Density Cholesterol and All-Cause Mortality in Older Adults: An Individual Patient Data Meta-AnalysisMilly A van der Ploeg, Rosalinde K E Poortvliet, Jonathan M K Bogaerts, et al.
Targeted Oncology|May 20, 2026
Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR TrialYu Sunakawa, Hisateru Yasui, Manabu Shiozawa, et al.
Age (Dordrecht, Netherlands)|October 29, 2013
The rs1333049 polymorphism on locus 9p21.3 and extreme longevity in Spanish and Japanese cohortsTomàs Pinós, Noriyuki Fuku, Yolanda Cámara, et al.
Age (Dordrecht, Netherlands)|November 28, 2014
FNDC5 (irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPsFabian Sanchis-Gomar, Nuria Garatachea, Zi-hong He, et al.
Frontiers in Aging Neuroscience|May 23, 2015
Exceptional longevity and muscle and fitness related genotypes: a functional in vitro analysis and case-control association replication study with SNPs THRH rs7832552, IL6 rs1800795, and ACSL1 rs6552828Noriyuki Fuku, Zi-Hong He, Fabian Sanchis-Gomar, et al.
Biomedical Reports|October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencingSatoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
British Journal of Cancer|October 4, 2017
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) studyEiji Shinozaki, Takayuki Yoshino, Kentaro Yamazaki, et al.
International Journal of Clinical Oncology|March 1, 2023
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutantChikako Nakai, Sachiyo Mimaki, Koutatsu Matsushima, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Cancer Medicine|August 29, 2023
Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit studySatoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
Clinical Colorectal Cancer|February 8, 2024
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit StudySatoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 14, 2023
The Role of a Composite Fitness Score in the Association Between Low-Density Cholesterol and All-Cause Mortality in Older Adults: An Individual Patient Data Meta-AnalysisMilly A van der Ploeg, Rosalinde K E Poortvliet, Jonathan M K Bogaerts, et al.
Targeted Oncology|May 20, 2026
Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR TrialYu Sunakawa, Hisateru Yasui, Manabu Shiozawa, et al.
Age (Dordrecht, Netherlands)|October 29, 2013
The rs1333049 polymorphism on locus 9p21.3 and extreme longevity in Spanish and Japanese cohortsTomàs Pinós, Noriyuki Fuku, Yolanda Cámara, et al.
Age (Dordrecht, Netherlands)|November 28, 2014
FNDC5 (irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPsFabian Sanchis-Gomar, Nuria Garatachea, Zi-hong He, et al.
Frontiers in Aging Neuroscience|May 23, 2015
Exceptional longevity and muscle and fitness related genotypes: a functional in vitro analysis and case-control association replication study with SNPs THRH rs7832552, IL6 rs1800795, and ACSL1 rs6552828Noriyuki Fuku, Zi-Hong He, Fabian Sanchis-Gomar, et al.
Biomedical Reports|October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencingSatoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
British Journal of Cancer|October 4, 2017
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) studyEiji Shinozaki, Takayuki Yoshino, Kentaro Yamazaki, et al.
International Journal of Clinical Oncology|March 1, 2023
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutantChikako Nakai, Sachiyo Mimaki, Koutatsu Matsushima, et al.
Pageof 14